SCHEMBL13699837

SCHEMBL13699837

NC(=O)c1oc2ccc(Cl)cc2c1NC(=O)COc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.61
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
TEAD1 P28347 1/20 0.53
YAP1 P46937 1/20 0.53
TEAD4 Q15561 1/20 0.53
TEAD2 Q15562 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 4/20 0.53
TP53 P04637 1/20 0.53
THRB P10828 1/20 0.52
CETP P11597 1/20 0.51
MAPK1 P28482 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
HPGD P15428 2/20 0.49
POLB P06746 1/20 0.49
PKM P14618 1/20 0.49
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699842 0.93 KDM4E (0.63) KDM4ENPC1RAB9ATEAD1YAP1
SCHEMBL13699836 0.87 ALDH1A1 (0.57) KDM4ETEAD1YAP1TEAD4TEAD2
SCHEMBL4260294 0.85 KDM4E (0.53) KDM4ENPC1RAB9ATEAD1YAP1
SCHEMBL13699841 0.85 KDM4E (0.58) KDM4ETEAD1YAP1TEAD4TEAD2
SCHEMBL13699835 0.84 KDM4E (0.70) KDM4ENPC1RAB9ATEAD1YAP1
SCHEMBL13699791 0.84 KDM4E (0.66) KDM4ETEAD1YAP1TEAD4TEAD2
SCHEMBL13699795 0.81 HPGD (0.75) KDM4ETEAD1YAP1TEAD4TEAD2
SCHEMBL1852546 0.81 KDM4E (0.72) KDM4ETEAD1YAP1TEAD4TEAD2
SCHEMBL13699838 0.80 MAPT (0.65) KDM4ENPC1RAB9AMAPTTP53
SCHEMBL4251178 0.79 ALDH1A1 (0.72) KDM4ETEAD1YAP1TEAD4TEAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885NPC1 3348/4885RAB9A 1928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.